GRIO


TRÉMOLLIÈRES

Dr Florence TRÉMOLLIÈRES

Bureau exécutif - Trésorière générale


Présentation > Les membres du Comité Directeur > Dr Florence TRÉMOLLIÈRES > Publications

PUBLICATIONS RÉCENTES


Rolland Y, Abellan Van Kan G, Benetos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C, Laroche M, Nourhashémi F, Orcel P, Piette F, Ribot C, Ritz P, Roux C, Taillandier J, Tremollieres F, Weryha G, Vellas B. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging. 2008;12(5):335-46

Trémollieres FA, Pouillès JM, Laparra J, Ribot C. Bone mineral density at menopause does not predict breast cancer incidence. Osteoporos Int. 2008 Mar 29. [Epub ahead of print]

Ribot C, Trémollieres F, Pouillés JM. Aromatase and regulation of bone remodeling. Joint Bone Spine. 2006;73(1):37-42. Epub 2005 Aug 1

Pouillès JM, Trémollieres FA, Ribot C. Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics. Osteoporos Int. 2006;17(2):193-200. Epub 2005 Jul 15

Trémollieres FA, Bauvin E, Cigagna F, Pouillès JM, Cauneille C, Arnaud C, Ribot C. Association of cardiovascular risk factors with intima-media thickness of the carotid arteries in early postmenopausal women. Menopause. 2004;11(3):323-30

Pouilles JM, Ribot C, Trémollières F. Is absorptiometry useful for monitoring osteoporosis treatment? Joint Bone Spine. 2001 Oct;68(5):367-9

Trémollieres FA, Pouilles JM, Ribot C. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women. Osteoporos Int. 2001;12(5):385-90

Pouillès JM, Tremollières FA, Martinez S, Delsol M, Ribot C. Ability of peripheral DXA measurements of the forearm to predict low axial bone mineral density at menopause. Osteoporos Int. 2001;12(1):71-6

Trémollières F. [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates] Gynecol Obstet Fertil. 2001;29(11):846-52

Pouilles JM, Ribot C, Trémollières F. Is absorptiometry useful for monitoring osteoporosis treatment? Joint Bone Spine. 2001;68(5):367-9

Trémollières FA, Pouilles JM, Ribot C. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women. Osteoporos Int. 2001;12(5):385-90

Pouilles JM, Trémollières FA, Martinez S, Delsol M, Ribot C. Ability of peripheral DXA measurements of the forearm to predict low axial bone mineral density at menopause. Osteoporos Int. 2001;12(1):71-6

Ribot C, Trémollières F, Pouilles JM. [Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis] Ann Med Interne (Paris). 2000;151(6):490-6.

Trémollières FA, Cigagna F, Alquier C, Cauneille C, Pouilles J, Ribot C. Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women. Atherosclerosis. 2000;153(1):81-8

Pouilles JM, Collard P, Trémollières F, Frayssinet P, Railhac JJ, Cahuzac JP, Autefage A, Ribot C. Accuracy and precision of in vivo bone mineral measurements in sheep using dual-energy X-ray absorptiometry. Calcif Tissue Int. 2000;66(1):70-3

Trémollières F, Ribot C. [Hormone replacement therapy in the prevention of osteoporosis. Evolution of therapeutic methods] Presse Med. 1999;28(22):1188-94.

Trémollières FA, Pouilles JM, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 women. Atherosclerosis. 1999;142(2):415-23

Trémollières F. [Can osteoporosis be prevented with low doses of estrogen?] J Gynecol Obstet Biol Reprod (Paris). 1998;27 Suppl 1:8-11

Ribot C, Trémollières F. Estrogens and osteoporosis. Rev Rhum Engl Ed. 1998;65(11):641-8

Tricoire J, Rolland M, Trémollières F, Ribot C. [Value of bone mineral content measurement in preterm infants given corticosteroids for bronchopulmonary dysplasia] Arch Pediatr. 1998;5(6):697-9

Ribot CA, Trémollières FA. Effect of estrogens on bone and other systems and hormonal substitute treatment. Curr Opin Rheumatol. 1997;9(4):362-9

Pouilles JM, Trémollières F, Roux C, Sebert JL, Alexandre C, Goldberg D, Treves R, Khalifa P, Duntze P, Horlait S, Delmas P, Kuntz D. Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy. Osteoporos Int. 1997;7(3):213-8

Trémollières FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol. 1996;175(6):1594-600

Jamrozik SI, Bennet AP, James-Deidier A, Trémollières F, Saint-Martin F, Dumoulin S, Valat-Coustols M, de Glisezinski I, Tremoulet M, Manelfe C, Louvet JP. Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patients. J Endocrinol Invest. 1996;19(7):472-9

Pouilles JM, Trémollières F, Ribot C. [Vertebral bone loss in perimenopause. Results of a 7-year longitudinal study] Presse Med. 1996;25(7):277-80

Pouilles JM, Trémollières F, Ribot C. Variability of vertebral and femoral postmenopausal bone loss: a longitudinal study. Osteoporos Int. 1996;6(4):320-4

Pouilles JM, Trémollières F, Ribot C. Effect of menopause on femoral and vertebral bone loss. J Bone Miner Res. 1995;10(10):1531-6

Ribot C, Pouilles JM, Trémollières F. Should we define osteoporosis based on bone mineral density criteria? Rev Rhum Engl Ed. 1995;62(9):546-8

Dernière mise à jour : 17-01-2017